TriAltus Bioscience
PrivateLast Round
Grant
Sep 15, 2021
Total Funding Raised
$1.93M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
TriAltus Bioscience operates in Healthcare & Life Sciences and is based in Birmingham, Alabama. Its latest recorded funding round was a Grant round in September 2021.
TriAltus Bioscience is a biotechnology company that develops and provides innovative protein purification and enzyme technology tools for life science research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TriAltus Bioscience Comparables
Compare TriAltus Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Protein Capture Science | 89% | |
| Cube Biotech | 83% | |
| Danaher Corporation | 72% |
For institutional investors. Book with your work email.
TriAltus Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 15, 2021 | ||||
| Seed | Apr 16, 2019 | ||||
| Grant | Nov 15, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
TriAltus Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alabama Launchpad | Seed, Grant |
| National Institutes of Health (NIH) | Grant |
| First Avenue Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 93% MoM.
- Sep 15, 2021
$257K grant received from the National Institutes of Health.
For institutional investors. Book with your work email.
TriAltus Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about TriAltus Bioscience's valuation, stock price, and market status.
Is TriAltus Bioscience a public or private company?
TriAltus Bioscience is a private company.
What is the current stock price of TriAltus Bioscience?
TriAltus Bioscience is a private company, so its shares have no public market price. Caplight tracks TriAltus Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TriAltus Bioscience worth (valuation)?
Valuation information for TriAltus Bioscience is not publicly available.
Can I buy TriAltus Bioscience stock?
TriAltus Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TriAltus Bioscience's last funding round?
TriAltus Bioscience's most recent funding round was Grant on September 15, 2021.
Who are the main investors in TriAltus Bioscience?
Key investors in TriAltus Bioscience include Alabama Launchpad, National Institutes of Health (NIH), First Avenue Ventures.
Will TriAltus Bioscience IPO soon?
No public IPO plans have been announced for TriAltus Bioscience.
How can I track TriAltus Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in TriAltus Bioscience's shares on secondary markets.